Invention Grant
- Patent Title: Five-membered heteroaryl-fused imidazole compound and application thereof
-
Application No.: US17574817Application Date: 2022-01-13
-
Publication No.: US11542272B2Publication Date: 2023-01-03
- Inventor: Tao Yu , Lu Gan , Chengde Wu , Shuhui Chen
- Applicant: Hangzhou Sciwind Biosciences Co., Ltd
- Applicant Address: CN Zhejiang
- Assignee: Hangzhou Sciwind Biosciences Co., Ltd
- Current Assignee: Hangzhou Sciwind Biosciences Co., Ltd
- Current Assignee Address: CN Zhejiang
- Agency: Harness, Dickey & Pierce, P.L.C.
- Priority: CN202010499820.5 20200604,CN202010676014.0 20200714,CN202010838768.1 20200819
- Main IPC: C07D495/04
- IPC: C07D495/04 ; A61P3/10 ; C07D487/04 ; C07D491/048 ; C07D498/04 ; C07D513/04
Abstract:
A novel five-membered heteroaromatic imidazole compound and use thereof is disclosed herein. Specifically, disclosed is a compound as shown in formula (III) or a pharmaceutically acceptable salt thereof. Also disclosed is a method for treating a disease related to GLP-1 receptor such as type II diabetes.
Public/Granted literature
- US20220135588A1 Five-Membered Heteroaryl-Fused Imidazole Compound And Application Thereof Public/Granted day:2022-05-05
Information query
